Orthofix Medical Inc.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-33.4M | $-36.0M | $-22.2M | $-28.9M | $-39.4M | $-60.9M | $-7.1M | $-10.7M |
| Depreciation & Amortization | $14.0M | $14.9M | $14.0M | $13.1M | $13.3M | $12.7M | $7.4M | $7.6M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $10.0M | $8.8M | $3.2M | $6.3M | $13.2M | $13.0M | $4.9M | $4.7M |
| Net Cash from Operating Activities | $9.0M | $-18.6M | $-6.7M | $477.0K | $-5.5M | $-34.0M | $2.3M | $-1.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $9.3M | $10.5M | $14.6M | $21.9M | $12.4M | $11.5M | $5.2M | $5.1M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-9.7M | $-10.9M | $-15.1M | $-22.3M | $-12.8M | $17.1M | $-5.9M | $-5.5M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $225.0K | $21.5M | $25.3M | $18.3M | $5.8M | $16.0M | $1.5M | $-252.0K |
| Net Change in Cash | $-598.0K | $-8.3M | $4.1M | $-3.9M | $-12.4M | $-732.0K | $-960.0K | $-7.9M |
| Free Cash Flow | $-360.0K | $-29.1M | $-21.3M | $-21.4M | $-17.9M | $-45.5M | $-2.9M | $-6.4M |